Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-013039
Filing Date
2022-02-08
Accepted
2022-02-08 08:29:36
Documents
1
Period of Report
2022-02-08

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm225802-3_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm225802-3_3seq1.xml 3 5132
  Complete submission text file 0001104659-22-013039.txt   6468
Mailing Address 750 LEXINGTON AVENUE, 6TH FLOOR NEW YORK NY 10024
Business Address
Hoberman Kenneth (Reporting) CIK: 0001573722 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41264 | Film No.: 22599377

Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Issuer) CIK: 0001875558 (see all company filings)

EIN.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations